Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
复制标题
DOI：
10.1089/thy.2010.0220
复制
发表时间：
2011-01-01
期刊：
影响因子：
6.6
通讯作者：
Bible, Keith C.
中科院分区：
文献类型：
--
作者：
Foote, Robert L.;Molina, Julian R.;Bible, Keith C.
背景资料：甲状腺未分化癌（ATC）的历史结局较差，中位生存期仅为5个月和32个月（范围：32-89个月;中位数：44个月），中位总Kaplan-Meier生存期为60个月。1年和2年的总生存率分别为70%和60%，
Background: Historical outcomes in anaplastic thyroid carcinoma (ATC) are poor, with a median survival of only 5 months and 32 months (range: 32-89 months; median: 44 months) with a median overall Kaplan-Meier survival of 60 months. Overall survival at 1 and 2 years was 70% and 60%, respectively, compared to